论文部分内容阅读
目的:观察倍他乐克对心肌梗塞患者院外治疗的效果。方法:选取179例病情稳定后出院的心肌梗塞患者,随机分为倍他乐克组与对照组。对照组68例采用常规吸氧、溶栓、止痛等治疗措施。倍他乐克组111例在采用药物治疗的同时配合每日口服倍他乐克50mg,连续服用24周。治疗6个月后,对两组疗效进行追踪评定。结果:倍他乐克组的治愈率、有效率、再发病住院率、死亡率均明显下降(P﹤0.05)。结论:倍他乐克可显著降低心肌梗塞患者院外再发病住院率和死亡率,提高心肌梗塞患者的院外生存质量。
Objective: To observe the effect of metoprolol on hospitalized patients with myocardial infarction. METHODS: A total of 179 patients with myocardial infarction who were discharged after stable condition were randomly divided into metoprolol and control groups. Control group, 68 cases of conventional oxygen, thrombolytic, analgesic and other treatment measures. Betaloc group 111 cases in the use of drug treatment at the same time with the daily oral Betaloc 50mg, for 24 weeks. After 6 months of treatment, the efficacy of the two groups were tracked. Results: The cure rate, effective rate, hospitalization rate and mortality rate of Betaloc group decreased significantly (P <0.05). Conclusion: Betaloc can significantly reduce the hospitalization rate and mortality of recurrent hospitalized patients with myocardial infarction, and improve the quality of life of patients with myocardial infarction.